This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Liquadd

Auriga Laboratories, Inc.

Drug Names(s): dextroamphetamine sulfate generic

Description: Liquadd is an oral solution of dextroamphetamine sulfate (5 mg/5 mL) designed for patients who have difficulty swallowing pills.

Liquadd is a generic of Dexedrine.

Deal Structure: On December 3, 2007, Auriga announced its acquisition of an exclusive license from Outlook Pharmaceuticals, to make, distribute, commercialize, market and sell in the United States Liquadd.

Partners: Outlook Pharmaceuticals, Inc.


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug